Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update of Nrf2 activators and inhibitors in cancer prevention/promotion
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103

Showing 51-75 of 103 citing articles:

Importance of Oxidative Stress and Antioxidant System in Health and Disease
Suna Sabuncuoğlu, Ahmet Yalçınkaya, Xian Zhou, et al.
Biochemistry (2022)
Open Access | Times Cited: 11
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs
Monika Gorska‐Arcisz, Marta Popęda, Marcin Braun, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
The role of Nrf2 signaling in parasitic diseases and its therapeutic potential
Mohammadamin Vatankhah, Reza Panahizadeh, Ali Safari, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32459-e32459
Open Access | Times Cited: 2
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications
Mangmang Qiu, Kang Ma, Junfeng Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Metabolism: an important player in glioma survival and development
Ning Wang, Yiru Yuan, Tianhao Hu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
NRF2 Modulators of Plant Origin and Their Ability to Overcome Multidrug Resistance in Cancers
Piotr Wadowski, Michał Juszczak, Katarzyna Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11500-11500
Open Access | Times Cited: 2
Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer
Tingying Xie, Husam Zahid, Ahmed R. Ali, et al.
Toxicology and Applied Pharmacology (2023) Vol. 460, pp. 116375-116375
Open Access | Times Cited: 6
Denervation aggravates renal ischemia reperfusion injury via BMAL1-mediated Nrf2/ARE pathway
Chong Dong, Jing Li, Qiao Tang, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 746, pp. 109736-109736
Open Access | Times Cited: 6
MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
Marialena Pouliou, Marianna A. Koutsi, Lydia Champezou, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4803-4803
Open Access | Times Cited: 5
Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway
Bhagyalakshmi Nair, J. Adithya, Gopika Chandrababu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4398-4413
Open Access | Times Cited: 4
Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2/HO-1 Signalling Pathway in Gastric Cancer Cells.
L Wang, Yi Zhou, Hui Lin, et al.
PubMed (2023) Vol. 25, Iss. 9, pp. 625-632
Closed Access | Times Cited: 4
Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma
Stefania Scicchitano, Maria Concetta Faniello, Maria Mesuraca
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14755-14755
Open Access | Times Cited: 4
An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis
Sarmistha Saha
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10049-10057
Open Access | Times Cited: 1
Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration‑resistant prostate cancer cells
Yi‐Jan Hsia, Zhang-Min Lin, Tao‐Lan Zhang, et al.
Oncology Reports (2024) Vol. 51, Iss. 5
Open Access | Times Cited: 1
PAQR4 oncogene: a novel target for cancer therapy
Dipti Patil, Swapnil Raut, Mitesh Joshi, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 1
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer
Jessica A. Moerland, Karen T. Liby
Antioxidants (2024) Vol. 13, Iss. 6, pp. 621-621
Open Access | Times Cited: 1
Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells
Dedy Hermansyah, Siti Syarifah, Adi Muradi Muhar, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 319-328
Open Access | Times Cited: 1
Tumoral Malignancy Decreases Coupled with Higher ROS and Lipid Peroxidation in HCT116 Colon Cancer Cells upon Loss of PRDX6
Daniel J. Lagal, Antonio M. Montes-Osuna, Alberto Ortiz-Olivencia, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 881-881
Open Access | Times Cited: 1
Epigenetic repression of de novo cysteine synthetases induces intra-cellular accumulation of cysteine in hepatocarcinoma by up-regulating the cystine uptake transporter xCT
Tomoaki Yamauchi, Yumi Okano, Daishu Terada, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling
Juan Zhang, Hong‐Xi Xu, Yulin Wu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Nitric oxide: Potential therapeutic target in Heat Stress–induced Multiple Organ Dysfunction
Priya Jaswal, Seema Bansal, Rishabh Chaudhary, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
Treatment of human cardiac fibroblasts with the protein arginine deiminase inhibitor BB-Cl-amidine activates the Nrf2/HO-1 signaling pathway
Aneta Stachowicz, Alia Sadiq, Brian Walker, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115443-115443
Open Access | Times Cited: 3
Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide.
Don Carlo Batara, Sang Wook Park, Hyun‐Jin Kim, et al.
PubMed (2023) Vol. 13, Iss. 9, pp. 4021-4038
Closed Access | Times Cited: 3
Molecular docking and In-Ovo analysis of human amniotic fluid extracellular vesicles loaded with sulforaphane: A potential therapy for neurological disorders
Mona Shahlaei, Maryam Saeidifar, Ali Zamanian
Colloids and Surfaces A Physicochemical and Engineering Aspects (2023) Vol. 670, pp. 131619-131619
Closed Access | Times Cited: 2
A State-of-the-Art Review on the Recent Advances of Mesenchymal Stem Cell Therapeutic Application in Systematic Lupus Erythematosus
Farshid Karimi, Babak Nejati, Fatemeh Sadat Rahimi, et al.
Immunological Investigations (2023) Vol. 53, Iss. 2, pp. 160-184
Closed Access | Times Cited: 2

Scroll to top